Pauline Gaboriaud

Title: Pauline Gaboriaud: Innovator in Monoclonal Antibody Development

Introduction

Pauline Gaboriaud is a notable inventor based in Esvres-sur-Indre, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on detecting infections caused by the BK polyomavirus, which is crucial for advancing medical diagnostics.

Latest Patents

Pauline Gaboriaud holds a patent for an innovative monoclonal antibody that targets the VP-1 protein of the BK polyomavirus. This invention, titled "Antibody targeting the VP-1 protein, fragments thereof, and uses of same for detecting infection with the BK polyomavirus," is designed to recognize various serotypes of the VP-1 protein. The patent highlights her contribution to improving detection methods for this viral infection, which can have significant health implications.

Career Highlights

Throughout her career, Gaboriaud has worked with esteemed institutions such as Université de Tours and Université de Picardie Jules Verne. Her research has focused on the intersection of immunology and virology, leading to advancements in diagnostic tools that can benefit public health.

Collaborations

Pauline has collaborated with notable colleagues, including Antoine Touze and Etienne Brochot. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.

Conclusion

Pauline Gaboriaud's work exemplifies the impact of innovative research in biotechnology. Her patent for a monoclonal antibody targeting the BK polyomavirus is a testament to her dedication to improving medical diagnostics. Through her career and collaborations, she continues to contribute to advancements in healthcare.